47,935 Shares in Sotera Health (NYSE:SHC) Bought by Texas Permanent School Fund

Texas Permanent School Fund bought a new position in Sotera Health (NYSE:SHCGet Rating) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 47,935 shares of the company’s stock, valued at approximately $939,000.

Several other hedge funds also recently bought and sold shares of the company. BlackRock Inc. boosted its holdings in Sotera Health by 7.6% in the 1st quarter. BlackRock Inc. now owns 6,252,520 shares of the company’s stock worth $135,429,000 after buying an additional 439,762 shares during the period. Victory Capital Management Inc. boosted its holdings in Sotera Health by 5.5% in the 1st quarter. Victory Capital Management Inc. now owns 2,653,434 shares of the company’s stock worth $57,454,000 after buying an additional 138,909 shares during the period. State Street Corp boosted its holdings in Sotera Health by 5.8% in the 1st quarter. State Street Corp now owns 1,434,849 shares of the company’s stock worth $31,079,000 after buying an additional 78,721 shares during the period. Equitable Trust Co. boosted its holdings in Sotera Health by 8.4% in the 2nd quarter. Equitable Trust Co. now owns 932,359 shares of the company’s stock worth $18,264,000 after buying an additional 72,240 shares during the period. Finally, William Blair Investment Management LLC bought a new position in Sotera Health in the 1st quarter worth $17,068,000. Institutional investors own 88.38% of the company’s stock.

Sotera Health Stock Up 1.2 %

Shares of NYSE SHC opened at $6.02 on Friday. The firm’s 50-day moving average price is $7.78 and its 200-day moving average price is $15.41. The company has a current ratio of 3.00, a quick ratio of 2.74 and a debt-to-equity ratio of 2.97. The stock has a market capitalization of $1.70 billion, a price-to-earnings ratio of 13.68 and a beta of 1.27. Sotera Health has a 12-month low of $5.78 and a 12-month high of $24.90.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on SHC shares. Royal Bank of Canada dropped their target price on shares of Sotera Health from $25.00 to $8.00 and set an “outperform” rating for the company in a report on Thursday, November 3rd. Citigroup downgraded shares of Sotera Health from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $25.00 to $9.00 in a report on Wednesday, October 5th. TheStreet downgraded shares of Sotera Health from a “c-” rating to a “d” rating in a report on Monday, September 19th. JPMorgan Chase & Co. dropped their price objective on shares of Sotera Health from $9.00 to $6.00 and set an “underweight” rating for the company in a report on Thursday, November 3rd. Finally, Barclays downgraded shares of Sotera Health from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $7.00 to $6.00 in a report on Tuesday, November 15th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, Sotera Health has an average rating of “Hold” and an average target price of $16.00.

Sotera Health Company Profile

(Get Rating)

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.

Read More

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health (NYSE:SHCGet Rating).

Institutional Ownership by Quarter for Sotera Health (NYSE:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.